Home
>
National Drug Code (NDC)
>
Ganciclovir
Ganciclovir - 63323-315-10 - (GANCICLOVIR SODIUM)
Drug Information of Ganciclovir
| Product NDC: | 63323-315 |
| Proprietary Name: | Ganciclovir |
| Non Proprietary Name: | GANCICLOVIR SODIUM |
| Active Ingredient(s): | 500 mg/10mL & nbsp; GANCICLOVIR SODIUM |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Ganciclovir
| Product NDC: | 63323-315 |
| Labeler Name: | APP Pharmaceuticals, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA090658 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100628 |
Package Information of Ganciclovir
| Package NDC: | 63323-315-10 |
| Package Description: | 25 VIAL in 1 TRAY (63323-315-10) > 10 mL in 1 VIAL |
NDC Information of Ganciclovir
| NDC Code | 63323-315-10 |
| Proprietary Name | Ganciclovir |
| Package Description | 25 VIAL in 1 TRAY (63323-315-10) > 10 mL in 1 VIAL |
| Product NDC | 63323-315 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | GANCICLOVIR SODIUM |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20100628 |
| Marketing Category Name | ANDA |
| Labeler Name | APP Pharmaceuticals, LLC |
| Substance Name | GANCICLOVIR SODIUM |
| Strength Number | 500 |
| Strength Unit | mg/10mL |
| Pharmaceutical Classes | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],DNA Polymerase Inhibitors [MoA],Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC] |
